214 related articles for article (PubMed ID: 33827115)
1. CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion.
Deng Y; Chatterjee B; Zens K; Zdimerova H; Müller A; Schuhmachers P; Ligeon LA; Bongiovanni A; Capaul R; Zbinden A; Holler A; Stauss H; Hammerschmidt W; Münz C
Blood; 2021 Jun; 137(23):3225-3236. PubMed ID: 33827115
[TBL] [Abstract][Full Text] [Related]
2. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.
Abolhassani H; Edwards ES; Ikinciogullari A; Jing H; Borte S; Buggert M; Du L; Matsuda-Lennikov M; Romano R; Caridha R; Bade S; Zhang Y; Frederiksen J; Fang M; Bal SK; Haskologlu S; Dogu F; Tacyildiz N; Matthews HF; McElwee JJ; Gostick E; Price DA; Palendira U; Aghamohammadi A; Boisson B; Rezaei N; Karlsson AC; Lenardo MJ; Casanova JL; Hammarström L; Tangye SG; Su HC; Pan-Hammarström Q
J Exp Med; 2017 Jan; 214(1):91-106. PubMed ID: 28011864
[TBL] [Abstract][Full Text] [Related]
3. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
[TBL] [Abstract][Full Text] [Related]
4. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.
Izawa K; Martin E; Soudais C; Bruneau J; Boutboul D; Rodriguez R; Lenoir C; Hislop AD; Besson C; Touzot F; Picard C; Callebaut I; de Villartay JP; Moshous D; Fischer A; Latour S
J Exp Med; 2017 Jan; 214(1):73-89. PubMed ID: 28011863
[TBL] [Abstract][Full Text] [Related]
5. Involvement of CD27/CD70 interactions in antigen-specific cytotoxic T-lymphocyte (CTL) activity by perforin-mediated cytotoxicity.
Yamada S; Shinozaki K; Agematsu K
Clin Exp Immunol; 2002 Dec; 130(3):424-30. PubMed ID: 12452832
[TBL] [Abstract][Full Text] [Related]
6. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4
Choi IK; Wang Z; Ke Q; Hong M; Qian Y; Zhao X; Liu Y; Kim HJ; Ritz J; Cantor H; Rajewsky K; Wucherpfennig KW; Zhang B
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E686-E695. PubMed ID: 29311309
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.
Sohlberg E; Saghafian-Hedengren S; Rasul E; Marchini G; Nilsson C; Klein E; Nagy N; Sverremark-Ekström E
J Immunol; 2013 Dec; 191(11):5669-76. PubMed ID: 24140645
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice.
Antsiferova O; Müller A; Rämer PC; Chijioke O; Chatterjee B; Raykova A; Planas R; Sospedra M; Shumilov A; Tsai MH; Delecluse HJ; Münz C
PLoS Pathog; 2014 Aug; 10(8):e1004333. PubMed ID: 25165855
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo.
Chatterjee B; Deng Y; Holler A; Nunez N; Azzi T; Vanoaica LD; Müller A; Zdimerova H; Antsiferova O; Zbinden A; Capaul R; Dreyer JH; Nadal D; Becher B; Robinson MD; Stauss H; Münz C
PLoS Pathog; 2019 May; 15(5):e1007748. PubMed ID: 31145756
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
Latour S; Fischer A
Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
[TBL] [Abstract][Full Text] [Related]
11. Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients.
Petrova M; Muhtarova M; Nikolova M; Magaev S; Taskov H; Nikolovska D; Krastev Z
World J Gastroenterol; 2006 Sep; 12(35):5711-6. PubMed ID: 17007027
[TBL] [Abstract][Full Text] [Related]
12. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
Wang Y; Aïssi-Rothe L; Virion JM; De Carvalho Bittencourt M; Ulas N; Audonnet S; Salmon A; Clement L; Venard V; Jeulin H; Stoltz JF; Decot V; Bensoussan D
Cytotherapy; 2014 Jan; 16(1):122-34. PubMed ID: 24094498
[TBL] [Abstract][Full Text] [Related]
13. Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection.
van Baarle D; Kostense S; Hovenkamp E; Ogg G; Nanlohy N; Callan MF; Dukers NH; McMichael AJ; van Oers MH; Miedema F
AIDS; 2002 Oct; 16(15):2001-11. PubMed ID: 12370498
[TBL] [Abstract][Full Text] [Related]
14. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
15. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
Angelini DF; Serafini B; Piras E; Severa M; Coccia EM; Rosicarelli B; Ruggieri S; Gasperini C; Buttari F; Centonze D; Mechelli R; Salvetti M; Borsellino G; Aloisi F; Battistini L
PLoS Pathog; 2013; 9(4):e1003220. PubMed ID: 23592979
[TBL] [Abstract][Full Text] [Related]
16. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia.
van Montfrans JM; Hoepelman AI; Otto S; van Gijn M; van de Corput L; de Weger RA; Monaco-Shawver L; Banerjee PP; Sanders EA; Jol-van der Zijde CM; Betts MR; Orange JS; Bloem AC; Tesselaar K
J Allergy Clin Immunol; 2012 Mar; 129(3):787-793.e6. PubMed ID: 22197273
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
[TBL] [Abstract][Full Text] [Related]
18. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
[TBL] [Abstract][Full Text] [Related]
19. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection.
Welten SP; Redeker A; Franken KL; Benedict CA; Yagita H; Wensveen FM; Borst J; Melief CJ; van Lier RA; van Gisbergen KP; Arens R
J Virol; 2013 Jun; 87(12):6851-65. PubMed ID: 23576505
[TBL] [Abstract][Full Text] [Related]
20. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]